Your browser is no longer supported. Please, upgrade your browser.
CareDx, Inc
Index- P/E- EPS (ttm)-0.41 Insider Own1.90% Shs Outstand51.18M Perf Week-15.07%
Market Cap3.21B Forward P/E103.12 EPS next Y0.64 Insider Trans-27.39% Shs Float50.47M Perf Month-14.49%
Income-18.70M PEG- EPS next Q0.05 Inst Own- Short Float8.90% Perf Quarter-26.15%
Sales192.20M P/S16.72 EPS this Y22.70% Inst Trans3.22% Short Ratio6.11 Perf Half Y22.15%
Book/sh9.21 P/B7.17 EPS next Y158.06% ROA- Target Price98.00 Perf Year134.04%
Cash/sh7.69 P/C8.58 EPS next 5Y20.00% ROE- 52W Range26.61 - 99.83 Perf YTD-8.90%
Dividend- P/FCF- EPS past 5Y19.00% ROI-6.00% 52W High-33.89% Beta0.66
Dividend %- Quick Ratio9.30 Sales past 5Y46.80% Gross Margin67.20% 52W Low147.98% ATR4.81
Employees456 Current Ratio9.60 Sales Q/Q75.50% Oper. Margin- RSI (14)40.61 Volatility9.45% 6.56%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume1.01 Prev Close64.21
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout- Avg Volume734.50K Price66.00
Recom1.70 SMA20-10.94% SMA50-6.66% SMA2008.49% Volume742,897 Change2.79%
Feb-26-21Downgrade H.C. Wainwright Buy → Neutral
Oct-30-20Reiterated H.C. Wainwright Buy $47 → $55
Oct-08-20Reiterated H.C. Wainwright Buy $45 → $47
Oct-02-20Reiterated H.C. Wainwright Buy $40 → $45
Aug-05-20Reiterated H.C. Wainwright Buy $37 → $40
Jun-26-20Initiated BTIG Research Buy $40
Jun-19-20Reiterated H.C. Wainwright Buy $40 → $37
Oct-01-19Resumed Craig Hallum Buy $48
May-09-19Upgrade H.C. Wainwright Neutral → Buy $30 → $43
Feb-15-19Initiated Jefferies Buy $35
Oct-23-18Resumed Raymond James Strong Buy $30
Sep-18-18Reiterated H.C. Wainwright Neutral $17 → $22
Nov-27-17Initiated H.C. Wainwright Buy $12
Jun-14-16Reiterated Mizuho Buy $12 → $8
Sep-29-15Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15Initiated Craig Hallum Buy
Mar-18-15Reiterated Mizuho Buy $15 → $12
May-13-21 07:00AM  
May-07-21 10:15AM  
May-05-21 06:55PM  
Apr-23-21 07:00AM  
Apr-22-21 11:38AM  
Apr-21-21 04:00PM  
Apr-20-21 07:00AM  
Apr-16-21 07:00AM  
Apr-08-21 07:00AM  
Apr-05-21 07:00AM  
Apr-03-21 06:12AM  
Mar-31-21 07:00AM  
Mar-23-21 07:00AM  
Mar-17-21 07:00AM  
Mar-15-21 12:38PM  
Mar-12-21 07:36AM  
Mar-11-21 04:05PM  
Mar-03-21 08:17AM  
Feb-26-21 12:31AM  
Feb-25-21 07:00AM  
Feb-24-21 08:30PM  
Feb-23-21 07:00AM  
Feb-12-21 07:00AM  
Feb-11-21 07:00AM  
Feb-10-21 07:00AM  
Feb-05-21 07:00AM  
Feb-02-21 12:37PM  
Jan-25-21 04:28PM  
Jan-20-21 10:56PM  
Jan-19-21 05:11PM  
Jan-11-21 07:00AM  
Jan-08-21 07:01AM  
Jan-07-21 07:00AM  
Jan-04-21 07:00AM  
Dec-31-20 07:10AM  
Dec-30-20 12:00PM  
Dec-23-20 07:29PM  
Dec-22-20 09:59AM  
Dec-21-20 07:06AM  
Dec-18-20 11:22AM  
Dec-17-20 10:30AM  
Dec-14-20 12:00PM  
Dec-01-20 07:00AM  
Nov-26-20 12:00PM  
Nov-25-20 07:00AM  
Nov-17-20 05:00AM  
Nov-14-20 08:00AM  
Nov-10-20 07:00AM  
Nov-06-20 07:05AM  
Oct-30-20 03:01PM  
Oct-29-20 06:45PM  
Oct-22-20 12:34PM  
Oct-21-20 11:23AM  
Oct-19-20 07:05AM  
Oct-15-20 04:05PM  
Oct-12-20 12:00PM  
Oct-09-20 03:30AM  
Oct-08-20 04:21PM  
Oct-07-20 04:05PM  
Oct-02-20 07:35AM  
Sep-24-20 07:00AM  
Sep-11-20 07:00AM  
Sep-10-20 07:00AM  
Sep-05-20 07:27AM  
Sep-02-20 07:00AM  
Aug-12-20 09:40AM  
Aug-05-20 07:11AM  
Aug-04-20 07:45PM  
Jul-30-20 07:00AM  
Jul-24-20 10:20PM  
Jul-16-20 04:05PM  
Jul-15-20 07:00AM  
Jun-29-20 01:29PM  
Jun-24-20 04:12PM  
Jun-22-20 07:00AM  
Jun-18-20 04:05PM  
Jun-15-20 04:05PM  
Jun-10-20 08:12PM  
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; and AlloSure Heart, a dd-cfDNA test to identify underlying cell injury leading to organ rejection. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors. CareDx, Inc. has a license agreement with Illumina, Inc. for the distribution, development and commercialization rights to NGS products and technologies; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bickerstaff GeorgeDirectorMay 12Sale63.0710,000630,74770,938May 13 09:11 PM
Maag PeterExecutive ChairMay 11Option Exercise12.2487,1281,066,447496,572May 12 06:53 PM
Goldberg MichaelDirectorMay 11Option Exercise2.9549,083144,574107,586May 12 06:56 PM
Goldberg MichaelDirectorMay 11Sale66.6049,0833,268,97258,503May 12 06:56 PM
Maag PeterExecutive ChairMay 11Sale66.6087,1285,802,799409,444May 12 06:53 PM
Maag PeterExecutive ChairMay 10Option Exercise9.6126,293252,741435,737May 12 06:53 PM
Goldberg MichaelDirectorMay 10Option Exercise2.9515,44245,48473,945May 12 06:56 PM
Goldberg MichaelDirectorMay 10Sale68.9415,4421,064,56158,503May 12 06:56 PM
Maag PeterExecutive ChairMay 10Sale68.9426,2931,812,623409,444May 12 06:53 PM
Maag PeterExecutive ChairMay 05Option Exercise27.1710,000271,700419,444May 06 08:55 PM
Maag PeterExecutive ChairMay 05Sale73.3210,000733,192409,444May 06 08:55 PM
Maag PeterExecutive ChairMay 03Option Exercise19.8715,086299,778428,054May 04 06:55 PM
Maag PeterExecutive ChairMay 03Sale76.6420,0001,532,723408,054May 04 06:55 PM
Maag PeterExecutive ChairApr 05Sale72.4010,000724,015412,968Apr 06 04:29 PM
Maag PeterExecutive ChairMar 05Sale61.2910,000612,852422,968Mar 05 08:45 PM
Seeto ReginaldSee RemarksMar 01Sale85.4510,704914,700142,634Mar 01 04:23 PM
Maag PeterExecutive ChairFeb 05Sale89.8210,000898,190412,800Feb 05 07:21 PM
SNYDERMAN RALPHDirectorJan 15Sale88.8812,0001,066,51372,672Jan 19 08:58 AM
King SashaChief Commercial OfficerJan 14Option Exercise9.209,87590,86653,306Jan 15 05:21 PM
King SashaChief Commercial OfficerJan 14Sale87.559,875864,59143,431Jan 15 05:21 PM
Cohen Fred EDirectorJan 06Option Exercise14.7415,000221,100105,893Jan 06 08:37 PM
Maag PeterExecutive ChairJan 05Option Exercise6.3110,00063,100431,974Jan 06 06:01 PM
Maag PeterExecutive ChairJan 05Sale71.9210,000719,237421,974Jan 06 06:01 PM
Seeto ReginaldSee RemarksDec 18Sale68.018,363568,801114,035Dec 18 08:40 PM
Goldberg MichaelDirectorDec 14Sale70.1930,0002,105,72257,404Dec 14 07:57 PM
Bickerstaff GeorgeDirectorDec 14Sale71.7610,000717,64480,487Dec 14 07:50 PM
Maag PeterExecutive ChairDec 07Option Exercise6.3110,00063,100431,974Dec 08 04:06 PM
Maag PeterExecutive ChairDec 07Sale66.3710,000663,667421,974Dec 08 04:06 PM
HAGSTROM WILLIAM ADirectorNov 12Option Exercise6.5010,00065,00028,575Nov 13 04:08 PM
HAGSTROM WILLIAM ADirectorNov 12Sale54.5910,000545,88818,575Nov 13 04:08 PM
Maag PeterExecutive ChairNov 05Option Exercise6.0810,00060,757431,974Nov 05 07:33 PM
Maag PeterExecutive ChairNov 05Sale53.4810,000534,791421,974Nov 05 07:33 PM
Bell Michael BrianChief Financial OfficerNov 03Option Exercise16.7525,640429,549135,917Nov 03 07:42 PM
Bell Michael BrianChief Financial OfficerNov 03Sale48.1532,5741,568,487103,343Nov 03 07:42 PM
King SashaChief Commercial OfficerOct 08Option Exercise9.3825,779241,73284,206Oct 09 05:03 PM
King SashaChief Commercial OfficerOct 08Sale50.6240,7752,064,21043,431Oct 09 05:03 PM
Maag PeterChief Executive OfficerOct 05Option Exercise5.9010,00059,000431,974Oct 06 06:11 PM
Maag PeterChief Executive OfficerOct 05Sale42.1110,000421,128421,974Oct 06 06:11 PM
Maag PeterChief Executive OfficerOct 01Option Exercise5.6720,000113,351441,974Oct 02 06:26 PM
Maag PeterChief Executive OfficerOct 01Sale40.5020,000809,972421,974Oct 02 06:26 PM
Maag PeterChief Executive OfficerSep 30Option Exercise5.4916,99293,286438,966Sep 30 08:10 PM
Maag PeterChief Executive OfficerSep 30Sale37.5916,992638,802421,974Sep 30 08:10 PM
Cohen Fred EDirectorSep 21Option Exercise5.1716,42484,90590,893Sep 22 09:14 PM
Maag PeterChief Executive OfficerSep 08Option Exercise5.4910,00054,900431,974Sep 08 05:46 PM
Maag PeterChief Executive OfficerSep 08Sale31.689,900313,609422,074Sep 08 05:46 PM
Maag PeterChief Executive OfficerAug 05Option Exercise5.3213,00869,247434,982Aug 07 05:56 PM
Maag PeterChief Executive OfficerAug 05Sale36.7713,008478,339421,974Aug 07 05:56 PM
Maag PeterChief Executive OfficerJul 06Option Exercise4.0010,00039,951431,974Jul 07 09:25 PM
Maag PeterChief Executive OfficerJul 06Sale34.2110,000342,098421,974Jul 07 09:25 PM
Maag PeterChief Executive OfficerJun 30Option Exercise2.309,26721,314400,156Jul 02 05:40 PM
Maag PeterChief Executive OfficerJun 30Sale35.0718,182637,719381,974Jul 02 05:40 PM
Maag PeterChief Executive OfficerJun 09Sale35.001,81863,630389,499Jun 11 07:44 PM
Maag PeterChief Executive OfficerJun 05Sale32.5850,0001,629,167391,317Jun 05 07:47 PM
King SashaChief Commercial OfficerJun 01Sale33.1025,402840,83928,334Jun 01 07:21 PM
Maag PeterChief Executive OfficerMay 19Sale32.2430,000967,122459,909May 19 06:16 PM